Bausch Health Companies I... (BHC)
NYSE: BHC
· Real-Time Price · USD
7.16
-0.19 (-2.59%)
At close: Sep 04, 2025, 11:17 AM
-2.59% (1D)
| Bid | 7.15 |
| Market Cap | 2.65B |
| Revenue (ttm) | 9.83B |
| Net Income (ttm) | 98M |
| EPS (ttm) | 0.26 |
| PE Ratio (ttm) | 27.54 |
| Forward PE | 1.84 |
| Analyst | Hold |
| Ask | 7.16 |
| Volume | 410,493 |
| Avg. Volume (20D) | 3,065,938 |
| Open | 7.30 |
| Previous Close | 7.35 |
| Day's Range | 7.12 - 7.31 |
| 52-Week Range | 4.25 - 9.85 |
| Beta | 0.41 |
Analyst Forecast
According to 0 analyst ratings, the average rating for BHC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Bausch Health Companies Inc. is scheduled to release its earnings on
Oct 29, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+4.74%
Bausch Health shares are trading higher after the ...
Unlock content with
Pro Subscription
1 month ago
-7.82%
Bausch Health shares are trading lower after the company reported mixed Q2 adjusted EPS results.
3 weeks ago · accessnewswire.com
Bausch Health Announces 2025 Gastrointestinal Health Scholars Program WinnersFor the Sixth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 Scholarship LAVAL, QC / ACCESS Newswire / August 7, 2025 / Bausch Health Companies Inc. (NYSE:BH...
1 month ago · seekingalpha.com
Bausch Health Companies Inc. (BHC) Q2 2025 Earnings Call TranscriptBausch Health Companies Inc. (NYSE:BHC ) Q2 2025 Earnings Conference Call July 30, 2025 5:00 PM ET Company Participants Garen Sarafian - VP & Head of Investor Relations Jean-Jacques Charhon - Executiv...
